Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.

Loading...

Date

2022-10

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

13
views
172
downloads

Citation Stats

Attention Stats

Abstract

A positive follow-up blood culture for methicillin-resistant Staphylococcus aureus (MRSA) while on seemingly appropriate therapy is a common and ominous development. However, the definition and management of persistent MRSA bacteremia is unstandardized. In this Opinion Paper, we identify the presence of bacteremia for > 1 calendar day as a "worry point" that should trigger an intensive diagnostic evaluation to identify metastatic infection sites. Next, we define the duration of MRSA bacteremia that likely constitutes antibiotic failure and outline a potential management algorithm for such patients. Finally, we propose pragmatic clinical trial designs to test treatment strategies for persistent MRSA bacteremia.

Department

Description

Provenance

Subjects

Humans, Bacteremia, Staphylococcal Infections, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus, Pragmatic Clinical Trials as Topic

Citation

Published Version (Please cite this version)

10.1093/cid/ciac364

Publication Info

Holland, Thomas L, Arnold S Bayer and Vance G Fowler (2022). Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(9). pp. 1668–1674. 10.1093/cid/ciac364 Retrieved from https://hdl.handle.net/10161/29594.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.